User login
A supplement to Clinical Psychiatry News and supported by Lilly.
This supplement has been developed based on the "New Clinical Strategies for the Recognition and Treatment of Bipolar Disorder: Can We Successfully Advance Care?" program that took place on September 14-15, 2007, in San Antonio, Texas. The intent is to provide best practices to clinicians relative to the diagnosis and treatment of bipolar disorder across the life span.
•FACULTY
•TARGET AUDIENCE
•EDUCATIONAL NEEDS
•LEARNING OBJECTIVES
•ACCREDITATION STATEMENT
•CREDIT DESIGNATION
To view the supplement, click the image above. To take the CME Posttest, download and print out the CME Posttest PDF file, and follow the test instructions.
FACULTY
Robert M.A. Hirschfeld, MDCo-Chair
Titus H. Harris Chair,
Harry K. Davis Professor,
Professor and Chair
Department of Psychiatry and Behavioral Sciences
The University of Texas Medical Branch
Galveston, Tex.
Dr Hirschfeld is a consultant and/or has participated in advisory boards for Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Cephalon, Eli Lilly, Forest Laboratories, GlaxoSmithKline, Janssen Pharmaceutica, Jazz Pharmaceuticals, KV Pharmaceutical, Novartis, Organon, Ortho-McNeil, Pfizer, Shire, Solvay Pharmaceuticals, and Wyeth-Ayerst.
Karen Dineen Wagner, MD, PhD
Marie B. Gale
Centennial Professor and Vice Chair
Department of Psychiatry and Behavioral Sciences
Director, Division of Child and Adolescent Psychiatry
The University of Texas Medical Branch
Galveston, Tex.
Dr Wagner receives grant/research support from the National Institute of Mental Health (NIMH) and is a consultant and/or has participated in advisory boards for Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Forest Laboratories, Janssen Pharmaceutica, Novartis, and Otsuka.
S. Nassir Ghaemi, MD, MPH
Associate Professor of Psychiatry and Public Health
Director, Bipolar Disorder Research Program
Emory University
Atlanta, Ga.
Dr Ghaemi receives research grants from, has participated in advisory boards for, and/or is on the speaker
A supplement to Clinical Psychiatry News and supported by Lilly.
This supplement has been developed based on the "New Clinical Strategies for the Recognition and Treatment of Bipolar Disorder: Can We Successfully Advance Care?" program that took place on September 14-15, 2007, in San Antonio, Texas. The intent is to provide best practices to clinicians relative to the diagnosis and treatment of bipolar disorder across the life span.
•FACULTY
•TARGET AUDIENCE
•EDUCATIONAL NEEDS
•LEARNING OBJECTIVES
•ACCREDITATION STATEMENT
•CREDIT DESIGNATION
To view the supplement, click the image above. To take the CME Posttest, download and print out the CME Posttest PDF file, and follow the test instructions.
FACULTY
Robert M.A. Hirschfeld, MDCo-Chair
Titus H. Harris Chair,
Harry K. Davis Professor,
Professor and Chair
Department of Psychiatry and Behavioral Sciences
The University of Texas Medical Branch
Galveston, Tex.
Dr Hirschfeld is a consultant and/or has participated in advisory boards for Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Cephalon, Eli Lilly, Forest Laboratories, GlaxoSmithKline, Janssen Pharmaceutica, Jazz Pharmaceuticals, KV Pharmaceutical, Novartis, Organon, Ortho-McNeil, Pfizer, Shire, Solvay Pharmaceuticals, and Wyeth-Ayerst.
Karen Dineen Wagner, MD, PhD
Marie B. Gale
Centennial Professor and Vice Chair
Department of Psychiatry and Behavioral Sciences
Director, Division of Child and Adolescent Psychiatry
The University of Texas Medical Branch
Galveston, Tex.
Dr Wagner receives grant/research support from the National Institute of Mental Health (NIMH) and is a consultant and/or has participated in advisory boards for Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Forest Laboratories, Janssen Pharmaceutica, Novartis, and Otsuka.
S. Nassir Ghaemi, MD, MPH
Associate Professor of Psychiatry and Public Health
Director, Bipolar Disorder Research Program
Emory University
Atlanta, Ga.
Dr Ghaemi receives research grants from, has participated in advisory boards for, and/or is on the speaker
A supplement to Clinical Psychiatry News and supported by Lilly.
This supplement has been developed based on the "New Clinical Strategies for the Recognition and Treatment of Bipolar Disorder: Can We Successfully Advance Care?" program that took place on September 14-15, 2007, in San Antonio, Texas. The intent is to provide best practices to clinicians relative to the diagnosis and treatment of bipolar disorder across the life span.
•FACULTY
•TARGET AUDIENCE
•EDUCATIONAL NEEDS
•LEARNING OBJECTIVES
•ACCREDITATION STATEMENT
•CREDIT DESIGNATION
To view the supplement, click the image above. To take the CME Posttest, download and print out the CME Posttest PDF file, and follow the test instructions.
FACULTY
Robert M.A. Hirschfeld, MDCo-Chair
Titus H. Harris Chair,
Harry K. Davis Professor,
Professor and Chair
Department of Psychiatry and Behavioral Sciences
The University of Texas Medical Branch
Galveston, Tex.
Dr Hirschfeld is a consultant and/or has participated in advisory boards for Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Cephalon, Eli Lilly, Forest Laboratories, GlaxoSmithKline, Janssen Pharmaceutica, Jazz Pharmaceuticals, KV Pharmaceutical, Novartis, Organon, Ortho-McNeil, Pfizer, Shire, Solvay Pharmaceuticals, and Wyeth-Ayerst.
Karen Dineen Wagner, MD, PhD
Marie B. Gale
Centennial Professor and Vice Chair
Department of Psychiatry and Behavioral Sciences
Director, Division of Child and Adolescent Psychiatry
The University of Texas Medical Branch
Galveston, Tex.
Dr Wagner receives grant/research support from the National Institute of Mental Health (NIMH) and is a consultant and/or has participated in advisory boards for Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Forest Laboratories, Janssen Pharmaceutica, Novartis, and Otsuka.
S. Nassir Ghaemi, MD, MPH
Associate Professor of Psychiatry and Public Health
Director, Bipolar Disorder Research Program
Emory University
Atlanta, Ga.
Dr Ghaemi receives research grants from, has participated in advisory boards for, and/or is on the speaker
